EKSO
Ekso Bionics Holdings Inc
NASDAQ: EKSO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$12.01
+4.98% today
Updated 2026-04-30
Market cap
$39.16M
P/E ratio
—
P/S ratio
3.06x
EPS (TTM)
$-4.91
Dividend yield
—
52W range
$3 – $14
Volume
0.1M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.5
Quality
C+2.0
Profitability
F4.0
Valuation
C4/9
Piotroski F-Score
Moderate
-13.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$9.50
-20.90%
12-Month target
—
—
Intrinsic (DCF)
$7.88
Margin of safety
-25.76%
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.31x — low leverage
Risks
- Altman Z -13.03 — distress zone
- Thin margins at -91.40%
- Negative free cash flow $-2.12M
- Revenue declining -38.30% QoQ
- 25.76% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $12.91M | $18.28M | $17.93M | $12.80M | $12.80M |
| Net income | $-15.08M | $-15.20M | $-11.33M | $-11.70M | $-6.88M |
| EPS | — | — | — | — | $-4.91 |
| Free cash flow | $-14.88M | $-12.21M | $-9.88M | $-11.99M | $-2.12M |
| Profit margin | -116.79% | -83.14% | -63.21% | -91.37% | -91.40% |
Peer comparison
Smart narrative
Ekso Bionics Holdings Inc trades at $12.01. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -13.03, it sits in the distress. TTM revenue stands at $12.80M. with profit margins at -91.40%. Our DCF model estimates intrinsic value at $7.88.
Frequently asked questions
What is Ekso Bionics Holdings Inc's stock price?
Ekso Bionics Holdings Inc (EKSO) trades at $12.01.
Is Ekso Bionics Holdings Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $7.88.
What is the price target of Ekso Bionics Holdings Inc (EKSO)?
The analyst target price is $9.50, representing -20.9% downside from the current price of $12.01.
What is the intrinsic value of Ekso Bionics Holdings Inc (EKSO)?
Based on our DCF model, intrinsic value is $7.88, a -25.8% margin of safety versus $12.01.
What is Ekso Bionics Holdings Inc's revenue?
TTM revenue is $12.80M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-13.03 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.06x
ROE-107.60%
Beta0.78
50D MA$10.59
200D MA$6.59
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—